Inventor profile of:

Matthew MCCLOREY

City:

Lawrence, Kansas

Country:

United States

Published Applications:

32

Last publication date:

2025-06-12

Top Assignees for applications by Matthew MCCLOREY

The entities that hold a legal rights for patent applications filed by inventor MCCLOREY Matthew:

Recent patent applications by MCCLOREY Matthew

Matthew MCCLOREY from Lawrence, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-12
US20250186390A1
Human necessities

Taxane Particles and Their Use

#2 | 2024-08-01
US20240252441A1
Human necessities

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

#3 | 2024-07-11
US20240226116A1
Human necessities

Glucocorticoid Particles and Their Use

#4 | 2023-11-23
US20230372234A1
Human necessities

Treatment of epithelial cysts by intracystic injection of antineoplastic particles

#5 | 2023-08-24
US20230263731A1
Human necessities

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

#6 | 2023-04-13
US20230111288A1
Human necessities

Treatment of epithelial cysts by intracystic injection of antineoplastic particles

#7 | 2022-03-31
US20220096423A1
Human necessities

Treatment of Bladder Cancer by Local Administration of Taxane Particles

#8 | 2022-02-17
US20220047513A1
Human necessities

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

#9 | 2021-12-23
US20210393569A1
Human necessities

Taxane Particles and Their Use

#10 | 2021-12-16
US20210387961A1
Chemistry; metallurgy

CIPROFLOXACIN POLYMORPH AND ITS USE

#11 | 2021-08-26
US20210259959A1
Human necessities

Treatment of epithelial cysts by intracystic injection of antineoplastic particles

#12 | 2021-07-15
US20210214683A1
Chemistry; metallurgy

METHODS FOR ISOLATING TUMOR-SPECIFIC IMMUNE CELLS FROM A SUBJECT FOR ADOPTIVE CELL THERAPY AND CANCER VACCINES

#13 | 2021-01-07
US20210000786A1
Human necessities

Taxane particles and their use

#14 | 2020-12-31
US20200405684A1
Human necessities

Taxane Particles and Their Use

#15 | 2020-08-20
US20200261367A1
Human necessities

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

#16 | 2020-08-06
US20200247780A1
Chemistry; metallurgy

Ciprofloxacin polymorph and its use

#17 | 2020-08-06
US20200246355A1
Human necessities

Glucocorticoid “nintedanib” particles and their use

#18 | 2020-05-28
US20200163928A1
Human necessities

Taxane particles and their use

#19 | 2020-04-02
US20200101039A1
Human necessities

Taxane particles and their use

#20 | 2020-02-27
US20200060969A1
Human necessities

Methods for treating lung disorders

#21 | 2019-12-05
US20190365700A1
Human necessities

Methods for Isolating Tumor-Specific Immune Cells from a Subject for Adoptive Cell Therapy and Cancer Vaccines

#22 | 2019-12-05
US20190365699A1
Human necessities

Treatment of Kidney Tumors by Intratumoral Injection of Taxane Particles

#23 | 2019-12-05
US20190365698A1
Human necessities

Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of Cancer

#24 | 2019-10-17
US20190314277A1
Human necessities

Methods for treating lung disorders

#25 | 2019-08-22
US20190254957A1
Human necessities

Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles

#26 | 2019-07-11
US20190209515A1
Human necessities

Treatment of Bladder Cancer by Intratumoral Injection of Taxane Particles

#27 | 2019-07-11
US20190209514A1
Human necessities

Treatment of Bladder Cancer by Local Administration of Taxane Particles

#28 | 2018-12-20
US20180360748A1
Human necessities

Methods for treating lung disorders

#29 | 2018-06-21
US20180169058A1
Human necessities

Taxane particles and their use

#30 | 2017-08-10
US20170224650A1
Human necessities

Methods for making compound particles

#31 | 2016-12-29
US20160374953A1
Human necessities

Methods for Making Compound Particles

#32 | 2016-12-08
US20160354336A1
Human necessities

Taxane particles and their use

InventorID:

1729373